Docetaxel, Paclitaxel
ATC CODE
- L01CD
INDICATIONS AND NEMLC RECOMMENDATIONS
INDICATIONS AND NEMLC RECOMMENDATIONS 1
INDICATION
- Adjuvant breast cancer.
NEMLC RECOMMENDATION
- Approved
Approved for patients with high grade, node positive ER negative disease.
REVIEW INDICATORS
- n/a
DATE RATIFIED
- 23 August 2012
INDICATIONS AND NEMLC RECOMMENDATIONS 2
INDICATION
- Metastatic breast cancer – first- and second-line.
NEMLC RECOMMENDATION
- Approved
REVIEW INDICATORS
- Change in the price of taxanes, specifically docetaxel.
DATE RATIFIED
- 16 September 2010